|
|
| | 4-METHYLTHIO-2-OXOBUTANOIC ACID SODIUM SALT Basic information |
| Product Name: | 4-METHYLTHIO-2-OXOBUTANOIC ACID SODIUM SALT | | Synonyms: | ALPHA-KETO-GAMMA-METHIOLBUTYRIC ACID SODIUM SALT;4-METHYLTHIO-2-OXOBUTANOIC ACID SODIUM SALT;sodium α-keto-(γ-methylthio)butyrate;4-methylthio-2-oxobutyric acid, sodium salt;α-keto-γ-(methylthio)butyric acid sodium salt;SODIUM-4-(METHYLTHIO)-2-OXOBUTANOATE;4-Methylthio-2-oxobutanoic acid sodium salt, 4-Methylthio-2-oxobutyric acid sodium salt, KMBA;A-keto-gamma-methiolbutyric acid sodium | | CAS: | 51828-97-8 | | MF: | C5H9NaO3S | | MW: | 172.17 | | EINECS: | | | Product Categories: | | | Mol File: | 51828-97-8.mol |  |
| | 4-METHYLTHIO-2-OXOBUTANOIC ACID SODIUM SALT Chemical Properties |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | RIDADR | UN 3335 | | WGK Germany | 3 |
| | 4-METHYLTHIO-2-OXOBUTANOIC ACID SODIUM SALT Usage And Synthesis |
| Uses | 4-Methylsulfanyl-2-oxobutanoic Acid Sodium Salt can be used to treat or prevent viral diseases. | | in vivo | MTOB sodium (860 mg/kg; IP, at 1 h and 18 h after the first injury) effectively suppresses the increases duration of righting reflex, and significantly decreased neurological severity score (NSS) scores[1]. | Animal Model: | C57BL/6 mice (traumatic brain injury)[1] | | Dosage: | 860 mg/kg | | Administration: | IP, at 1 h and 18 h after the first injury | | Result: | Effectively suppressed the increased duration of righting reflex, and significantly decreased NSS scores. |
|
| | 4-METHYLTHIO-2-OXOBUTANOIC ACID SODIUM SALT Preparation Products And Raw materials |
|